HitChem
HitChem speeds early-stage drug discovery by combining AI-driven molecule design with practical chemistry services. Its platform uses cheminformatics, language models, and high-throughput screening to design and validate hit compounds. Category: B2B platform for pharma research, with integrations to HTVS, SAR, and CADD. Key offerings include diverse small molecule libraries (53,359-strong diversity library, CRBN-focused library, cyclic peptides, Sp3-enriched library, covalent library) and a 2D Molecular Generation Model. The company targets biotech and pharmaceutical labs seeking faster hit generation and lead optimization at scale.
HitChem
HitChem speeds early-stage drug discovery by combining AI-driven molecule design with practical chemistry services. Its platform uses cheminformatics, language models, and high-throughput screening to design and validate hit compounds. Category: B2B platform for pharma research, with integrations to HTVS, SAR, and CADD. Key offerings include diverse small molecule libraries (53,359-strong diversity library, CRBN-focused library, cyclic peptides, Sp3-enriched library, covalent library) and a 2D Molecular Generation Model. The company targets biotech and pharmaceutical labs seeking faster hit generation and lead optimization at scale.